

Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
| Headquarter | Audubon Biomedical Science, & Technology Park, 3960 Broadway New York City, NY United States of America |
|---|---|
| Website | www.intracellulartherapies.com |
| Founding Date | 2002 |
| Tel | 2129233388 |
| Company Status | Public |
| Stock | ITCI |
Intra-Cellular Therapies competitors include IFT-CHARLES RIVER LABO FR SAFETY. Intra-Cellular Therapies ranks 1st in Overall Culture Score on Comparably vs its competitors. See below how Intra-Cellular Therapies compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
1 employee at Intra-Cellular Therapies has reviewed Intra-Cellular Therapies across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users in New York about their company is that it was very prepared on their first day. New York employees concluded that their overall onboarding experience was positive. 74% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Intra-Cellular Therapies employees have provided insight into whether or not they clearly understand Intra-Cellular Therapies' KPIs and OKRs.

Sharon Mates CEO / President
Sharon Mates serves as the CEO / President of Intra-Cellular Therapies.

Kimberly E. Vanover Ph.D. Senior Vice President of Clinical Development
Dr. Kimberly E. Vanover, Ph.D. has been Senior Vice President of Clinical Development at Intra-Cellular Therapies, Inc....

Robert E. Davis Ph.D. Senior VP & Chief Scientific Officer
Dr. Robert E. Davis, Ph.D. has been Chief Scientific Officer and Senior Vice President at Intra-Cellular Therapies, Inc....

Lawrence J. Hineline CPA VP of Finance, CFO, Treasurer & Assistant Secretary
Mr. Lawrence J. Hineline, CPA, has been Chief Financial Officer, Vice President of Finance and Treasurer at...

Michael I. Halstead J.D. Senior VP, General Counsel, Corporate Compliance Officer & Secretary
Mr. Michael I. Halstead has been Senior Vice President and General Counsel at Intra-Cellular Therapies, Inc., since July...

Daniel Utzinger VP & CIO
Daniel Utzinger serves as the VP & CIO for Intra-Cellular Therapies. Daniel started at Intra-Cellular Therapies in March...

Susan Kozauer VP Clinical Development
Susan Kozauer serves as the VP Clinical Development for Intra-Cellular Therapies. Susan started at Intra-Cellular...

Andrew Satlin Chief Medical Officer
Andrew Satlin serves as the Chief Medical Officer for Intra-Cellular Therapies. Andrew started at Intra-Cellular...

Mark Neumann Executive Vice President, Chief Commercial Officer
Mark Neumann serves as the Executive Vice President, Chief Commercial Officer of Intra-Cellular Therapies. Mark...

No Recent Jobs found for Intra-Cellular Therapies on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Intra-Cellular Therapies address?
Intra-Cellular Therapies location is at Audubon Biomedical Science, & Technology Park, 3960 Broadway
Who is the CEO of Intra-Cellular Therapies?
Intra-Cellular Therapies CEO is Sharon Mates, their score by employees is 100
What is Intra-Cellular Therapies eNPS?
The eNPS for Intra-Cellular Therapies is 100
Who are Intra-Cellular Therapies competitors?
Intra-Cellular Therapies main competitors are IFT-CHARLES RIVER LABO FR SAFETY
Who is Intra-Cellular Therapies leadership?
Kimberly E. Vanover Ph.d., Robert E. Davis Ph.d. & Lawrence J. Hineline Cpa are part of Intra-Cellular Therapies leadership, Sharon Mates is the CEO